Wednesday, June 28, 2017
Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the Japanese Intellectual Property Office has publicized its intent to grant Oramed a patent titled, "Methods and Compositions for Treating Diabetes" The patent covers Oramed's invention of an oral insulin and glucagon-like peptide-1 (GLP-1) analog combination composition (or therapy).
